Selective serotonin reuptake inhibitorprescribing before, during and after pregnancy: a population-bas ed study in six Europe anregions
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Selective serotonin reuptake inhibitorprescribing before, during and after pregnancy : a population-bas ed study in six Europe anregions. / Charlton, Ra; Jordan, S; Pierini, A; Garne, Ester; Neville, Aj; Hansen, Av; Gini, R; Thayer, D; Tingay, K; Puccini, A; Bos, Hj; Andersen, Anne-Marie Nybo; Sinclair, M; Dolk, H; de Jong-van den Berg, Ltw.
In: B J O G, Vol. 122, No. 7, 2015, p. 1010-1020.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Selective serotonin reuptake inhibitorprescribing before, during and after pregnancy
T2 - a population-bas ed study in six Europe anregions
AU - Charlton, Ra
AU - Jordan, S
AU - Pierini, A
AU - Garne, Ester
AU - Neville, Aj
AU - Hansen, Av
AU - Gini, R
AU - Thayer, D
AU - Tingay, K
AU - Puccini, A
AU - Bos, Hj
AU - Andersen, Anne-Marie Nybo
AU - Sinclair, M
AU - Dolk, H
AU - de Jong-van den Berg, Ltw
N1 - © 2014 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists.
PY - 2015
Y1 - 2015
N2 - OBJECTIVE: To explore the prescribing patterns of selective serotonin reuptake inhibitors (SSRIs) before, during and after pregnancy in six European population-based databases.DESIGN: Descriptive drug utilisation study.SETTING: Six electronic healthcare databases in Denmark, the Netherlands, Italy (Emilia Romagna/Tuscany), Wales and the rest of the UK.POPULATION: All women with a pregnancy ending in a live or stillbirth starting and ending between 2004 and 2010.METHODS: A common protocol was implemented across databases to identify SSRI prescriptions issued (UK) or dispensed (non-UK) in the year before, during or in the year following pregnancy.MAIN OUTCOME MEASURES: The percentage of deliveries in which the woman received an SSRI prescription in the year before, during or in the year following pregnancy. We also compared the choice of SSRIs and changes in prescribing over the study period.RESULTS: In total, 721 632 women and 862 943 deliveries were identified. In the year preceding pregnancy, the prevalence of SSRI prescribing was highest in Wales [9.6%; 95% confidence interval (CI95 ), 9.4-9.8%] and lowest in Emilia Romagna (3.3%; CI95 , 3.2-3.4%). During pregnancy, SSRI prescribing had dropped to between 1.2% (CI95 , 1.1-1.3%) in Emilia Romagna and 4.5% (CI95 , 4.3-4.6%) in Wales. The higher UK pre-pregnancy prescribing rates resulted in higher first trimester exposures. After pregnancy, SSRI prescribing increased most rapidly in the UK. Paroxetine was more commonly prescribed in the Netherlands and Italian regions than in Denmark and the UK.CONCLUSIONS: The higher SSRI prescribing rates in the UK, compared with other European regions, raise questions about differences in the prevalence and severity of depression and its management in pregnancy across Europe.
AB - OBJECTIVE: To explore the prescribing patterns of selective serotonin reuptake inhibitors (SSRIs) before, during and after pregnancy in six European population-based databases.DESIGN: Descriptive drug utilisation study.SETTING: Six electronic healthcare databases in Denmark, the Netherlands, Italy (Emilia Romagna/Tuscany), Wales and the rest of the UK.POPULATION: All women with a pregnancy ending in a live or stillbirth starting and ending between 2004 and 2010.METHODS: A common protocol was implemented across databases to identify SSRI prescriptions issued (UK) or dispensed (non-UK) in the year before, during or in the year following pregnancy.MAIN OUTCOME MEASURES: The percentage of deliveries in which the woman received an SSRI prescription in the year before, during or in the year following pregnancy. We also compared the choice of SSRIs and changes in prescribing over the study period.RESULTS: In total, 721 632 women and 862 943 deliveries were identified. In the year preceding pregnancy, the prevalence of SSRI prescribing was highest in Wales [9.6%; 95% confidence interval (CI95 ), 9.4-9.8%] and lowest in Emilia Romagna (3.3%; CI95 , 3.2-3.4%). During pregnancy, SSRI prescribing had dropped to between 1.2% (CI95 , 1.1-1.3%) in Emilia Romagna and 4.5% (CI95 , 4.3-4.6%) in Wales. The higher UK pre-pregnancy prescribing rates resulted in higher first trimester exposures. After pregnancy, SSRI prescribing increased most rapidly in the UK. Paroxetine was more commonly prescribed in the Netherlands and Italian regions than in Denmark and the UK.CONCLUSIONS: The higher SSRI prescribing rates in the UK, compared with other European regions, raise questions about differences in the prevalence and severity of depression and its management in pregnancy across Europe.
U2 - 10.1111/1471-0528.13143
DO - 10.1111/1471-0528.13143
M3 - Journal article
C2 - 25352424
VL - 122
SP - 1010
EP - 1020
JO - BJOG: An International Journal of Obstetrics and Gynaecology
JF - BJOG: An International Journal of Obstetrics and Gynaecology
SN - 0140-7686
IS - 7
ER -
ID: 135533462